dpi 201-106 has been researched along with propranolol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futaki, S; Goto, Y; Ohgoshi, Y; Suga, H; Yaku, H | 1 |
| Almquist, A; Benditt, DG; Goldenberg, IF; Gornick, CC; Milstein, S; Tuna, IC; Walker, MJ | 1 |
| Berthold, R; Herzig, JW; Markstein, R; Quast, U; Salzmann, R; Scholtysik, G | 1 |
| Bormann, G; Hof, RP; Rüegg, UT; Salzmann, R; Zierhut, W | 1 |
4 other study(ies) available for dpi 201-106 and propranolol
| Article | Year |
|---|---|
Similar oxygen cost of myocardial contractility between DPI 201-106 and epinephrine despite different subcellular mechanisms of action in dog hearts.
Topics: Animals; Calcium Channels; Catecholamines; Dogs; Dose-Response Relationship, Drug; Energy Metabolism; Epinephrine; Hemodynamics; Myocardial Contraction; Oxygen Consumption; Perfusion; Piperazines; Propranolol; Sodium Channels; Ventricular Function, Left | 1992 |
Cardiac electrophysiologic effects of orally administered DPI 201-106 in conscious canines: effects of pharmacologic autonomic blockade or cardiac transplantation.
Topics: Administration, Oral; Animals; Atrioventricular Node; Atropine; Autonomic Agents; Denervation; Dogs; Electric Stimulation; Electrophysiology; Heart; Heart Transplantation; Piperazines; Propranolol; Refractory Period, Electrophysiological; Sinoatrial Node; Transplantation, Homologous | 1989 |
DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties.
Topics: Action Potentials; Animals; Cats; Cyclic AMP; Female; Guinea Pigs; Heart; Heart Rate; Male; Myocardial Contraction; Phosphoric Diester Hydrolases; Piperazines; Propranolol; Protein Kinase Inhibitors; Rabbits; Sarcolemma; Stereoisomerism | 1985 |
Pharmacological actions of SDZ 218-135, a novel positive inotropic agent.
Topics: Adenosine Triphosphate; Anesthesia; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Disease Models, Animal; Electrophysiology; Female; Guinea Pigs; Heart Atria; Hemodynamics; Isometric Contraction; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Ovum; Papillary Muscles; Phosphodiesterase Inhibitors; Piperazines; Potassium; Propranolol; Pyrimidinones; Rabbits; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Triazoles | 1994 |